dc.contributor.author |
Cumpston, Miranda S |
|
dc.contributor.author |
Webb, Steven A |
|
dc.contributor.author |
Middleton, Philippa |
|
dc.contributor.author |
Sharplin, Greg |
|
dc.contributor.author |
Green, Sally |
|
dc.contributor.author |
Australian Clinical Trials Alliance Reference Group on Impact and Implementation of CTN Trials |
|
dc.coverage.spatial |
England |
|
dc.date.accessioned |
2024-04-08T04:02:42Z |
|
dc.date.available |
2024-04-08T04:02:42Z |
|
dc.date.issued |
2021-03 |
|
dc.identifier.citation |
(2021). Trials, 22(1), 232-. |
|
dc.identifier.issn |
1745-6215 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/68098 |
|
dc.description.abstract |
<h4>Background</h4>The translation of evidence from clinical trials into practice is complex. One approach to facilitating this translation is to consider the 'implementability' of trials as they are designed and conducted. Implementability of trials refers to characteristics of the design, execution and reporting of a late-phase clinical trial that can influence the capacity for the evidence generated by that trial to be implemented. On behalf of the Australian Clinical Trials Alliance (ACTA), the national peak body representing networks of clinician researchers conducting investigator-initiated clinical trials, we conducted a pragmatic literature review to develop a concept map of implementability.<h4>Methods</h4>Documents were included in the review if they related to the design, conduct and reporting of late-phase clinical trials; described factors that increased or decreased the capacity of trials to be implemented; and were published after 2009 in English. Eligible documents included systematic reviews, guidance documents, tools or primary studies (if other designs were not available). With an expert reference group, we developed a preliminary concept map and conducted a snowballing search based on known relevant papers and websites of key organisations in May 2019.<h4>Results</h4>Sixty-five resources were included. A final map of 38 concepts was developed covering the domains of validity, relevance and usability across the design, conduct and reporting of a trial. The concepts drew on literature relating to implementation science, consumer engagement, pragmatic trials, reporting, research waste and other fields. No single resource addressed more than ten of the 38 concepts in the map.<h4>Conclusions</h4>The concept map provides trialists with a tool to think through a range of areas in which practical action could enhance the implementability of their trials. Future work could validate the strength of the associations between the concepts identified and implementability of trials and investigate the effectiveness of steps to address each concept. ACTA will use this concept map to develop guidance for trialists in Australia.<h4>Trial registration</h4>This review did not include health-related outcomes and was therefore not eligible for registration in the PROSPERO register. |
|
dc.format.medium |
Electronic |
|
dc.language |
eng |
|
dc.publisher |
Springer Nature |
|
dc.relation.ispartofseries |
Trials |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.rights.uri |
https://creativecommons.org/licenses/by/4.0/ |
|
dc.subject |
Australian Clinical Trials Alliance Reference Group on Impact and Implementation of CTN Trials |
|
dc.subject |
Humans |
|
dc.subject |
Publications |
|
dc.subject |
Research Personnel |
|
dc.subject |
Australia |
|
dc.subject |
Applicability |
|
dc.subject |
Clinical trials |
|
dc.subject |
Implementability |
|
dc.subject |
Implementation |
|
dc.subject |
Knowledge translation |
|
dc.subject |
Late-phase trials |
|
dc.subject |
Pragmatic trials |
|
dc.subject |
32 Biomedical and Clinical Sciences |
|
dc.subject |
3202 Clinical Sciences |
|
dc.subject |
42 Health Sciences |
|
dc.subject |
Clinical Trials and Supportive Activities |
|
dc.subject |
Clinical Research |
|
dc.subject |
6 Evaluation of treatments and therapeutic interventions |
|
dc.subject |
6.9 Resources and infrastructure (treatment evaluation) |
|
dc.subject |
Generic health relevance |
|
dc.subject |
1102 Cardiorespiratory Medicine and Haematology |
|
dc.subject |
1103 Clinical Sciences |
|
dc.subject |
4202 Epidemiology |
|
dc.subject |
4203 Health services and systems |
|
dc.title |
Understanding implementability in clinical trials: a pragmatic review and concept map. |
|
dc.type |
Journal Article |
|
dc.identifier.doi |
10.1186/s13063-021-05185-w |
|
pubs.issue |
1 |
|
pubs.begin-page |
232 |
|
pubs.volume |
22 |
|
dc.date.updated |
2024-03-10T22:11:16Z |
|
dc.rights.holder |
Copyright: The authors |
en |
dc.identifier.pmid |
33771197 (pubmed) |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/33771197 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
review-article |
|
pubs.subtype |
Review |
|
pubs.subtype |
Journal Article |
|
pubs.elements-id |
893153 |
|
pubs.org-id |
Liggins Institute |
|
pubs.org-id |
University management |
|
pubs.org-id |
LiFePATH |
|
pubs.org-id |
Office of the Vice-Chancellor |
|
dc.identifier.eissn |
1745-6215 |
|
dc.identifier.pii |
10.1186/s13063-021-05185-w |
|
pubs.number |
232 |
|
pubs.record-created-at-source-date |
2024-03-11 |
|
pubs.online-publication-date |
2021-03-26 |
|